Get started
Author

Adeline Cuggia

Cancer Risks Associated With GermlinePALB2Pathogenic Variants: An International Study of 524 Families
2019 · Xin Yang, Goska Leslie, et al. · Journal of Clinical Oncology · 435
PDF
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
2021 · Talia Golan, Grainne M. O’Kane, et al. · Gastroenterology · 155
Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes
2017 · Christophe Cassinotto, Jaron Chong, et al. · European Journal of Radiology · 95
Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
2016 · Qing Li, Hao Wang, et al. · Oncotarget · 65
A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
2020 · Yifan Wang, Jin Yong Patrick Park, et al. · Clinical Cancer Research · 30
PDF
Reflex Testing for GermlineBRCA1,BRCA2,PALB2, andATMMutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research Registries
2018 · Alyssa L. Smith, Cavin Wong, et al. · JCO Precision Oncology · 28
PDF
Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing
2021 · Yifan Wang, Bryn Golesworthy, et al. · Journal of Medical Genetics · 23
Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease
2017 · Christophe Cassinotto, Anthony Dohan, et al. · European Journal of Radiology · 19
A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene
2019 · Cavin Wong, Fei Chen, et al. · PLoS Genetics · 17
PDF
Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
2022 · Bryn Golesworthy, Yifan Wang, et al. · Frontiers in Oncology · 16
Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?
2022 · Yifan Wang, Adeline Cuggia, et al. · Journal of the National Comprehensive Cancer Network · 9
Pancreatic Cancer Progression in a Patient With Lynch Syndrome Receiving Immunotherapy: A Cautionary Tale
2021 · Yifan Wang, Adeline Cuggia, et al. · Journal of the National Comprehensive Cancer Network · 9
PDF
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative
2025 · Tess Aalto, Maria Abacan, et al. · Cancer Cell · 5
Abstract B066: Convergent cell-state programs characterize BRCA2 -reversion-independent resistance in pancreatic cancer
2026 · Joan Miguel Romero, Yifan Wang, et al. · Cancer Research
773 Evaluation of Blood-based Molecular Biomarker Test for the Surveillance of Individuals at High Risk for Pancreatic Cancer
2026 · Randall Brand, Aimee L. Lucas, et al. · Gastrointestinal Endoscopy
773 Evaluation of Blood-based Molecular Biomarker Test for the Surveillance of Individuals at High Risk for Pancreatic Cancer
2026 · Randall Brand, Aimee L. Lucas, et al. · Gastroenterology
ATM c.7374_7375insAlu is a French-Canadian founder pathogenic variant associated with predisposition to pancreatic and breast cancer
2026 · Yifan Wang, Celine Domecq, et al. · Journal of Medical Genetics
Abstract 3339: Evaluation of GATA6 and KRT17 immunostaining for subtype classification in pancreatic ductal adenocarcinoma
2025 · Ruomeng Fang, Joan Miguel Romero, et al. · Cancer Research
Supplementary Table 1 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
2023 · Yifan Wang, Jin Yong Patrick Park, et al.
Supplementary Figure 7 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
2023 · Yifan Wang, Jin Yong Patrick Park, et al.
Supplementary Table 2 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
2023 · Yifan Wang, Jin Yong Patrick Park, et al.
PDF
Supplementary Figure 5 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
2023 · Yifan Wang, Jin Yong Patrick Park, et al.
PDF
Supplementary Figure 8 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
2023 · Yifan Wang, Jin Yong Patrick Park, et al.
PDF
Supplementary Figure 4 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
2023 · Yifan Wang, Jin Yong Patrick Park, et al.
Supplementary Figure 3 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
2023 · Yifan Wang, Jin Yong Patrick Park, et al.
Works count: 49
Citation count: 944
H-index: 11
I10-index: 11
Year
Topic
Type